Read as much as you want on BostonGlobe.com, anywhere and anytime, for just 99¢.

Roche pays $220m for Westborough company

Swiss diagnostics and drug company Roche bought the Westborough blood testing company Constitution Medical Investors for $220 million on Tuesday.

Roche, which calls itself the world’s largest biotech company, will utilize Constitution Medical Investors’ Bloodhound, a blood testing technology that is designed to provide fast and accurate diagnosis of blood-related diseases. Bloodhound, a device currently in development and not yet approved by the Food and Drug Administration, is the core technology of an automated system that has the capacity to increase laboratory efficiency and to save space.

Continue reading below

CMI is a health care investment firm that focuses on early-stage technology funding, specifically with medical devices and testing that diagnoses disease and infection.

In addition to the $220 million paid upfront, the deal also includes the possibility of more payments, depending on whether or not the company reaches “certain milestones,” according to the agreement.

Gail Waterhouse can be reached at gail.waterhouse@globe.com. Follow her on Twitter at @gailwaterhouse.
Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week